Cargando…
Peritumoural ground-glass opacity associated with tumour pseudoprogression in a patient with non-small cell lung cancer treated with nivolumab
Nivolumab, a monoclonal antibody to programmed cell death protein-1 (PD-1), has revolutionised the management of patients with advanced non-small cell lung cancer (NSCLC). Treatment with nivolumab is associated with toxicities known as immune-related adverse events. Although pneumonitis is a potenti...
Autores principales: | Kato, Ryoji, Hayashi, Hidetoshi, Tanizaki, Junko, Tanaka, Kaoru, Takeda, Masayuki, Nakagawa, Kazuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
ESMO Open
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519799/ https://www.ncbi.nlm.nih.gov/pubmed/28761729 http://dx.doi.org/10.1136/esmoopen-2016-000145 |
Ejemplares similares
-
Peritumoural Strain Elastography of Newly Diagnosed Breast Tumours: Does Maximum Peritumoural Halo Depth Correlate with Tumour Differentiation and Grade?
por: Gruber, Leonhard, et al.
Publicado: (2023) -
Peripheral consolidation/ground-glass opacities
por: Marchiori, Edson, et al.
Publicado: (2020) -
GROUND GLASS OPACITIES: IT'S NOT ALL COVID
por: RAMIREZ, LEANDRO, et al.
Publicado: (2021) -
Ground-glass opacities with subpleural sparing
por: Marchiori, Edson, et al.
Publicado: (2021) -
Ground-glass opacities accompanied by pulmonary cysts
por: Marchiori, Edson, et al.
Publicado: (2020)